Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells C Ma, M Han, B Heinrich, Q Fu, Q Zhang, M Sandhu, D Agdashian, ... Science 360 (6391), eaan5931, 2018 | 880 | 2018 |
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection CM Theriot, MJ Koenigsknecht, PE Carlson Jr, GE Hatton, AM Nelson, ... Nature communications 5 (1), 3114, 2014 | 879 | 2014 |
Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine CM Theriot, AA Bowman, VB Young MSphere 1 (1), e00045-15, 2016 | 334 | 2016 |
High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution BJ Callahan, J Wong, C Heiner, S Oh, CM Theriot, AS Gulati, SK McGill, ... Nucleic acids research 47 (18), e103-e103, 2019 | 293 | 2019 |
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile CM Theriot, VB Young Annual review of microbiology 69, 445-461, 2015 | 286 | 2015 |
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection AE Reeves, CM Theriot, IL Bergin, GB Huffnagle, PD Schloss, VB Young Gut microbes 2 (3), 145-158, 2011 | 277 | 2011 |
Diversification of host bile acids by members of the gut microbiota JA Winston, CM Theriot Gut microbes 11 (2), 158-171, 2020 | 233 | 2020 |
Hydrolysis of organophosphorus compounds by microbial enzymes CM Theriot, AM Grunden Applied Microbiology and Biotechnology 89, 35-43, 2011 | 181 | 2011 |
Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains CM Theriot, CC Koumpouras, PE Carlson, II Bergin, DM Aronoff, ... Gut microbes 2 (6), 326-334, 2011 | 170 | 2011 |
Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids R Thanissery, JA Winston, CM Theriot Anaerobe 45, 86-100, 2017 | 167 | 2017 |
Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract MJ Koenigsknecht, CM Theriot, IL Bergin, CA Schumacher, PD Schloss, ... Infection and immunity 83 (3), 934-941, 2015 | 151 | 2015 |
Metabolic model-based integration of microbiome taxonomic and metabolomic profiles elucidates mechanistic links between ecological and metabolic variation C Noecker, A Eng, S Srinivasan, CM Theriot, VB Young, JK Jansson, ... MSystems 1 (1), e00013-15, 2016 | 149 | 2016 |
Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract MH Foley, S O’Flaherty, R Barrangou, CM Theriot PLoS pathogens 15 (3), e1007581, 2019 | 148 | 2019 |
Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection AM Seekatz, CM Theriot, K Rao, YM Chang, AE Freeman, JY Kao, ... Anaerobe 53, 64-73, 2018 | 140 | 2018 |
Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract JA Winston, CM Theriot Anaerobe 41, 44-50, 2016 | 122 | 2016 |
Fecal microbiota transplantation eliminates Clostridium difficile in a murine model of relapsing disease AM Seekatz, CM Theriot, CT Molloy, KL Wozniak, IL Bergin, VB Young Infection and immunity 83 (10), 3838-3846, 2015 | 122 | 2015 |
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials K Selle, JR Fletcher, H Tuson, DS Schmitt, L McMillan, GS Vridhambal, ... MBio 11 (2), e00019-20, 2020 | 100 | 2020 |
Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection CM Theriot, VB Young Gut microbes 5 (1), 86-95, 2014 | 91 | 2014 |
Shifts in the gut metabolome and Clostridium difficile transcriptome throughout colonization and infection in a mouse model JR Fletcher, S Erwin, C Lanzas, CM Theriot Msphere 3 (2), e00089-18, 2018 | 83 | 2018 |
Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection CM Bassis, CM Theriot, VB Young Antimicrobial agents and chemotherapy 58 (5), 2767-2774, 2014 | 75 | 2014 |